Sarah Dry

Sarah Dry serves as Department Chair and Professor of Clinical in the Department of Pathology and Laboratory Medicine at UCLA's David Geffen School of Medicine. With over 100 publications spanning more than a decade, she has established herself as a leading expert in sarcoma pathology and soft tissue tumor diagnostics. Her work bridges laboratory science with clinical practice, focusing on improving diagnostic criteria and treatment approaches for complex tumors.

Dr. Dry's research interests center on sarcoma classification, tumor biology, and cancer diagnostics, with particular expertise in liposarcoma, dedifferentiation processes, and soft tissue tumors. She has made significant contributions to understanding molecular pathways in sarcomas and developing standardized reporting systems for cancer pathology. Her work on the International Collaboration on Cancer Reporting (ICCR) datasets has helped establish consistent diagnostic criteria for sarcomas worldwide. She has also investigated gender disparities in academic pathology leadership and contributed to NCCN guidelines for sarcoma treatment.

Analysis of Dr. Dry's publication record reveals a strong focus on translational sarcoma research, with emphasis on molecular diagnostics, tumor classification systems, and therapeutic targets. Her work spans basic science investigations of tumor biology to clinical implementation of diagnostic standards. Recent publications demonstrate increasing attention to precision oncology approaches, molecular biomarkers, and the development of standardized reporting frameworks that have been adopted internationally.

Dr. Dry has contributed significantly to multiple National Comprehensive Cancer Network (NCCN) guidelines for sarcoma treatment and has served on committees developing standardized reporting systems through the International Collaboration on Cancer Reporting. Her work on gender representation in pathology editorial boards has drawn attention to diversity issues in academic medicine leadership.

As Department Chair, Dr. Dry leads one of the nation's premier academic pathology departments, overseeing clinical services, research initiatives, and educational programs. Her leadership extends to national organizations where she has helped shape standards for cancer reporting and diagnosis. She collaborates extensively with the UCLA Sarcoma Program, contributing pathology expertise to multidisciplinary tumor boards and clinical trials.